At NMCC, we aggressively manage cancer and the side effects of the disease and treatment to help patients feel better so they spend more time at home. This method of treatment is called a "medical home," and we're so successful at it that our CEO Dr. Barbara McAneny received a grant to duplicate the process at six clinics across the country. As part of the grant, we offer treatment until 8 p.m. during the week and from 1 to 4 p.m. on weekends so our patients don't seek care in the ER. By extending our hours, we keep patients out of the hospital and at home where they're happy and comfortable.
Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer
Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Supp... Continue Reading
More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatm... Continue Reading
NMCC’s CEO Dr. Barbara McAneny spoke recently about pancreatic cancer and how it’s treated. Listen to the interview here.
NMCC’s Dr. Jose Avitia spoke with KKOB’s Terrie Q. Sayre about healthcare and cancer care. Listen to the interview here.
New Mexico Cancer Center (NMCC) is one of six award winners for the 2014 Association of Community Cancer Centers’ (ACCC) Innovator Awards. Established in 2011, ACCC’s Innovator Awards honor exceptional cancer programs that demonstrate forward-thinking strategic planning and have delivered pioneering, replicable programs for cancer care delivery. As an award recipient, NMCC presented the details and outcomes of their ongoing work at the ACCC National Oncology Conference before more than 500 cancer care providers from across the country in San Diego last month. Read about the event here.